Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,720 total articles
Atlassian's Rovo AI platform and expanding cloud revenue are driving faster customer adoption and a sudden re-rating. The stock looks actionable on a pullback: enter $160, stop $150, target $200 over a mid-term 45 trading day horizon. Key risks include guidance deceleration, competition, and momentum exhaustion.
Ameresco's pivot into AI-scale power infrastructure - driven by a reported $1.5 billion backlog - creates a discrete re-rating opportunity. The company trades at $21.38 with a market cap near $1.13B, EV $2.96B and EV/EBITDA ~11.7. This trade targets a rebound to $30 on successful deployment and integration, with a stop at $19 to protect against exe…
Corpay has assembled the building blocks for a step-change in its Corporate Payments revenue: a strategic Mastercard investment, exclusive large-ticket cross-border arrangement, and the AvidXchange acquisition. Fundamentals show healthy free cash flow and strong ROE, while valuation metrics (P/E ~24, EV/EBITDA ~14) leave room for multiple expansion…
Siemens Healthineers remains an attractive way to play durable demand in imaging and diagnostics. The combination of an installed base that supports high-margin services, accelerating AI-enabled software monetization, and steady capital equipment replacement cycles supports a constructive trade into H2 2026. I recommend a long with a $49.00 entry, …
Scott Bessent’s reported large-scale re-entry into Bitcoin may have flipped the narrative for institutional adoption. This trade plan lays out a mid-term long on BTC with explicit entry, stop and target, why the market should care, key catalysts, and a balanced risk section with counterarguments.
Hewlett Packard Enterprise has pivoted into AI infrastructure with a record $5.9B backlog and Juniper integration that stitches compute, storage and networking. Valuation is rich versus history but still reasonable given free cash flow and balance-sheet strength. This is a mid-term swing trade for traders looking to capture backlog conversion and p…
Seneca Foods (SENEA) has more than doubled off its 52-week low to roughly $194, but the setup still looks constructive: $230M+ free cash flow, modest leverage (debt/equity 0.29) and a sub-12x P/E. This trade idea lays out an actionable long with entry, stop and target tied to technicals and valuation, plus the catalysts and risks to watch.
Teleflex (TFX) has been through a rough multi-year stretch but management's plan to pay down $800M of debt, execute $1B of buybacks and focus the portfolio — combined with a first-of-its-kind FDA approval from a Teleflex subsidiary — make this an actionable long trade. The business still looks cheap on an operational cash-flow basis versus the mark…
Niu's latest report disappointed sentiment and knocked the ADS down, yet underlying unit trends in China remain strong (Q2 sales 434,687 units; China +25% YoY). At a $153M market cap and an RSI near 33, NIU presents a tactical long with a clear entry, stop and target for a mid-term swing (45 trading days). This is a trade, not a long-term endorseme…
Power Solutions International (PSIX) has the financial profile of a mid-cap industrial benefitting from data-center electrification: healthy free cash flow ($67.1M), a reasonable EV/EBITDA of 8.96 and a P/E of 12.4. Legal noise and margin pressure have knocked the stock down from a $119.70 52-week high to the mid-$30s. We see a mispricing: if PSIX …
NuScale Power (SMR) is a commercially pre-revenue SMR vendor whose shares plunged from 2025 highs and now trade near the low end of their 52-week range. The company has NRC approval, a committed Romania project and an announced pathway to a potential Tennessee Valley Authority (TVA) power purchase agreement expected by the end of 2026. That PPA is …
Triple Flag Precious Metals (TFPM) is priced to capture a tide of higher gold prices while its Ravenswood optionality and steady dividend cushion downside. The stock trades at $33.79 with a $6.97B market cap, favorable technical momentum, and a modest yield ahead of an 08/31/2026 ex-dividend. This trade idea sizes an entry at $33.25, stop at $30.50…
Johnson & Johnson looks like an attractive dip-buy for patient, income-minded investors. The stock trades near $271 with a 52-week range of $173 to $276. J&J's core fundamentals - $651B market cap, $22.2B free cash flow, 24.8% ROE and modest leverage - support a continued re-rating if new labels and continued CAPLYTA uptake accelerate growth. We're…
Energy Fuels (UUUU) sits at the intersection of uranium production and rare-earth element (REE) processing. The market is wrestling with a large $1.9B magnet-maker acquisition, meaningful shareholder dilution and ongoing unprofitability, but the company now has Department of Defense conditional financing and a uniquely positioned White Mesa Mill to…
Eli Lilly is trading with strong momentum after a string of product wins and encouraging R&D timing. With blockbuster GLP-1 sales already driving revenue growth and a favorable technical backdrop, a mid-term long makes sense. Entry $1254.77, target $1350.00, stop $1150.00—plan horizon: mid term (45 trading days).
Nvidia remains the AI infrastructure bellwether, but its valuation and near-term technicals leave little margin for an earnings miss. This trade idea lays out a mid-term (45 trading days) long setup to buy a post-earnings pullback, with concrete entry, stop, and target levels, a rationale grounded in cash flow and market share, and a clear checklis…
iShares High Yield Systematic Bond ETF (HYDB) offers a near 7% distribution yield and a rules-based approach to selecting high-yield bonds. The ETF's multifactor screening (default probability, default-adjusted spreads, volatility) aims to control credit risk while harvesting yield. We favor a mid-term long trade to capture coupon income plus modes…
eBay is trading below several of its short-term moving averages, but fundamentals still look solid: $2.43B in free cash flow, a mid-20s P/E on adjusted earnings, and recent revenue momentum. This trade targets a rebound back toward prior highs while protecting downside with a tight stop.
CoreWeave's top-line is finally translating into healthier unit economics. Q2 revenue of $2.6B, accelerating utilization among hyperscaler customers and a clearer path to margin expansion support a constructive trade. Valuation still prices growth and execution risk - we lay out an actionable long with a $88 entry, $120 target and $75 stop, with st…
Tempus AI pairs clinical-scale genomic sequencing with software that turns data into clinical decisions. At roughly $3.2B market value, the stock prices in growth but not perfection. We recommend a structured long: entry $8.50, stop $6.00, target $15.00 on a 180-trading-day horizon, backed by accelerating revenue, expanding gross margins and a grow…
DocuSign is profitable, producing meaningful free cash flow and showing early traction for its AI-powered Intelligent Agreement Management (IAM) suite. The stock trades at a reasonable FCF yield but still sits below prior multiples. This trade idea targets a multiple re-rating as IAM adoption and buybacks compress share count and lift earnings-per-…
Hammond Power Solutions has the product set and balance-sheet profile to capture outsized demand from AI-driven data-center and industrial electrification projects. With a market cap of roughly $2.09B, a thin public float and improving technical setup after a deep pullback, HMDPF is a tactical long for investors willing to hold through order cadenc…
TG Therapeutics' BRIUMVI has turned revenue momentum into higher guidance and market attention. At a market cap near $8.3B and a P/E around 19.8, the stock already prices growth; still, accelerating sales, favorable technicals and elevated short interest make a mid-term long trade compelling for disciplined traders. This idea lays out entry, stop a…
Meta is a cash-generative, high-ROE platform trading at a mid-20s earnings multiple and sitting well below its 52-week high. With hyperscaler AI spending accelerating and large investors adding to positions, we upgrade Meta to a buy and lay out a swing trade with strict risk controls: entry $552.95, stop $520, target $650.
OPENLANE (OPLN) checks the boxes for an event-driven long: improving top-line momentum, positive 2026 guidance, healthy free cash flow ($218.6M), and a valuation that could re-rate if private equity or strategic buyers pursue an exit. Enter $33.00, stop $29.00, target $44.00; horizon: long term (180 trading days).
